Journal
Frontiers in Oncology
Publication Date
1-1-2023
Volume
13
First Page
1280587
Document Type
Open Access Publication
DOI
10.3389/fonc.2023.1280587
Rights and Permissions
Mosleh E, Snyder S, Wu N, Willis DN, Malone R and Hayashi RJ (2023) Factors influencing delayed clearance of high dose methotrexate (HDMTX) in pediatric, adolescent, and young adult oncology patients. Front. Oncol. 13:1280587. doi: 10.3389/fonc.2023.1280587 © 2023 Mosleh, Snyder, Wu, Willis, Malone and Hayashi. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
Recommended Citation
Mosleh, Ema; Snyder, Stacy; Wu, Ningying; Willis, Daniel N; Malone, Rema; and Hayashi, Robert J, "Factors influencing delayed clearance of high dose methotrexate (HDMTX) in pediatric, adolescent, and young adult oncology patients." Frontiers in Oncology. 13, 1280587 (2023).
https://digitalcommons.wustl.edu/oa_4/3515
Department
ICTS (Institute of Clinical and Translational Sciences)
Corrigendum
